With over two decades of leadership across diagnostics, clinical research, and regulated product development, Dr. Mustafa Poonawala brings an unmatched depth of experience to Dynamill CRO. A proven R&D and clinical operations executive, he has overseen portfolios exceeding $500 million, led global teams across diagnostics giants like Becton Dickinson & Company, and driven over 30 product launches—including multiple clinical trials for IVDR, EUA and 510(k) regulatory pathways.

Dr. Poonawala founded Dynamill CRO to fill a critical gap in the clinical research landscape: a premier, diagnostics-focused CRO designed from the ground up to accelerate trial timelines, improve trial quality, and deliver regulatory confidence. His vision for Dynamill is rooted in scientific rigor, operational excellence, and the transformative power of AI-first digital tools. Under his leadership, Dynamill CRO is redefining how diagnostic trials are executed—with speed and predictability.